Scientists launch a pre-emptive strike on deadly post-transplant infection

(University of Cambridge) A potential new treatment to protect immunosuppressed patients from human cytomegalovirus (HCMV) has been discovered by scientists at the University of Cambridge. Their study shows that certain epigenetic inhibitors expose and help to destroy dormant HCMV infections, which often reactivate to cause serious illness and death in these vulnerable groups. Subject to clinical trials, their proposed 'shock and kill' treatment strategy offers hope to transplant patients across the world.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news